2Weiss,Lee WT,Woo KT.Slow continuius ultrafiltration(SCUF)the safe efficient treatment for patient with cardiac failure and overload[J].Singapore Med J,2001,36(5):276.
3Marenzi G,Agostoni P.Hemofiltration in heart failure[J].Int J Artif Organs,2004,27(12):1070-6.
4Bart BA,Boyle A,Bank AJ,etal.Ultrafiltration versu usual care for hospitalized patients with heart failure:the relief for acutely fluid overloaded patients with decompensated congestive heart failure(RAPID-CHF)trial[J].J Am Coll Cardiol,2005,46(11):2043-6.
二级参考文献10
1Fisher ML,Gottlieb SS,Plotnick GD,et al.Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial[].Journal of the American College of Cardiology.1994
2Pitt B,Zannad F,Remme WJ,et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure.Randomized Aldactone Evaluation Study Investigators[].The New England Journal of Medicine.1999
3MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)[].The Lancet.1999
4Packer M,Coats AJ,Fowler MB,et al.Effect of carvedilol on survival in severe chronic heart failure[].The New England Journal of Medicine.2001
5Garg R,Yusuf S.Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure.Collaborative Group on ACE Inhibitor Trials[].The Journal of The American Medical Association.1995
6Packer M,Bristow MR,Cohn JN,et al.The effect of carvedilol on morbidity and mortality in patients with chronic heart failure.U. S. Carvedilol Heart Failure Study Group[].The New England Journal of Medicine.1996
7Vantrimpont P,Rouleau JL,Wun CC,et al.Additive beneficial effects of beta-blockers to angiotensin converting enzyme inhibitors in the Survival and Ventricular Enlargement ( SAVE) Study.SAVE Investigators[].Journal of the American College of Cardiology.1997
8The SOLVD Investigators.Studies of Left Ventricular Dysfunction ( SOLVD).Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction[].The New England Journal of Medicine.1992
9ACC/AHA Task Force Report.Guidelines for the evaluation and management of heart failure[].Circulation.1995
10Yusuf S,Sleight P,Pogue J,et al.Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.The Heart Outcomes Prevention Evaluation Study Investigators[].The New England Journal of Medicine.2000
4Cleland JG. Daubert JC,Erdmann E,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005,352 : 1539 - 1549.
5Bart BA,Boyle A,Bank AJ. U;Trafiltration versu usual care for hospitalized patients with heart failure:the relief for acutely fluid overloaded patients with decompensated congestive heart failure(PAPID-CHF)trial[J].Journal of the American College of Cardiology,2005,(11):2043-2046.doi:10.1016/j.jacc.2005.05.098.
6Schrier RW.Role of diminished renal function in cardiovascular mortality:marker or pathogenetic factor[J].J Am Coll Cardiol,2006,47(1):1-8.
7Costanzo MR,Saltzberg M,O’Sullivan J,et al.Early ultrafiltration in patients with decompensated heart failure and diuretic resistance[J].J Am Coll Cardiol,2005,46(11):2047-2051.
8Bart BA,Goldsmith SR,Lee KL,et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome[J].N Engl J Med,2012,367(24):2296-2304.
